This event is now sold out. Please contact the organizer for more details or view other events from British Chamber of Commerce in Japan.
- Doors Open
Guests arrival and check-in
- Welcome and Introductions
BCCJ Representative will deliver opening remarks and introduce panellists.
- Opening Remarks
Philippe Fauchet•Kenji Shibuya•Takafumi HoriiOpening remarks and introduction: Overview of UK and Japan’s drug approval and innovation ecosystems by Philippe Fauchet and Kenji Shibuya.
Philippe Fauchet
Founder of Mirasense Partners
Kenji Shibuya
CEO of Medical Excellence Japan
Takafumi Horii
President & Representative Director of AstraZeneca K.K.
- Panel Discussion
Alison Beale•Philippe Fauchet•Takafumi Horii•Kenji ShibuyaPanel Discussion led by Alison Beale.
Alison Beale
Director Japan Office of University of OxfordPhilippe Fauchet
Founder of Mirasense PartnersTakafumi Horii
President & Representative Director of AstraZeneca K.K.Kenji Shibuya
CEO of Medical Excellence Japan
- Q&A Session
Alison Beale•Philippe Fauchet•Takafumi Horii•Dr Alicia Demirjian•Kenji ShibuyaQ&A Session led by Alison Beale
Alison Beale
Director Japan Office of University of OxfordPhilippe Fauchet
Founder of Mirasense PartnersTakafumi Horii
President & Representative Director of AstraZeneca K.K.
Dr Alicia Demirjian
Medical Epidemiologist at UK Health Security AgencyKenji Shibuya
CEO of Medical Excellence Japan
- Closing Remarks
Dr Alicia DemirjianClosing remarks from BCCJ Representative and Dr Alicia Demirjan from the UK Health Security Agency
Dr Alicia Demirjian
Medical Epidemiologist at UK Health Security Agency
- Close